HOME >> MEDICINE >> NEWS
New data supports CellCept's position as a world leader in solid organ transplantation

m creatinine levels were observed over two years, reinforcing CellCept's nephroprotective profile.

Grostzner J, Kaczmarek I, Mueller M, et al. Calcineurin-inhibitor-free immunosuppression with mycophenolate mofetil and sirolimus after cardiac transplantation is safe and improves renal function significantly: 1 year follow-up. Abstract 449, ATC 2004.
In this study of 30 heart transplant patients data showed that conversion from a CNI-based immunosuppressant regimen to CellCept and sirolimus in patients with chronic kidney failure is safe, preserves graft function and improves kidney function. This may help avoid CNI-related nephrotoxicity, a common problem after heart transplantation, which can lead to increased morbidity and impairment of patients' quality of life.

in adult kidney transplant patients
Abramowicz D, Gafner N, Wijngaard P. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomised study. Abstract 1527, ATC 2004.
In a study of 151 stable renal transplant patients, where CNI was withdrawn from a CellCept-based immunosuppressant regimen, there was no impact on five-year graft and patient survival. Beneficial effects were observed in kidney function, as well as lipid profile, blood pressure and malignancy rate. These data show that CellCept is safe to use long term as part of a low-toxicity immunosuppressant regimen and allows CNI-sparing, thus avoiding associated kidney toxicity, high cholesterol and high blood pressure, which can lead to impaired graft function.

Kessler M, Frimat L, Charpentier B, et al. Renal function evaluation after half dose reduction of Neoral in combination with CellCept in renal transplant patients with altered renal function: preliminary 2 year safety and efficacy results of the MMF REFERENCE study: a randomised, open, multicentre, prospective, controlled study. Abstract 462, ATC 20
'"/>

Contact: Cendrine Banerjee-Quetel
cendrine.banerjee-quetel@ketchum.com
44-207-611-3656
Ketchum
19-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. Emergency department study supports giving dehydrated children fluids by mouth
2. Review supports link between HRT and stroke
3. Chamomile tea: New evidence supports health benefits
4. Social supports lessen effects of maltreatment on children vulnerable to depression
5. Study supports the use of mechanical assistance
6. Study supports aggressive treatment of heart patients with cholesterol-lowering medication
7. NCI grant supports Jefferson trial to study test for colorectal cancer recurrence
8. Study supports new theory for nicotines protective effect against neurodegenerative disorders
9. New study supports use of PET scans in early diagnosis of Alzheimers disease
10. Contraception study supports convenience, simplicity
11. International grant supports study related to preventing organ rejection

Post Your Comments:
(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated 1 ... a number of health disorders and medical conditions. However, ... within the medical community. Many women are suffering from ... body fat around the waist area (truncal obesity), but ... by PCOS. , Awareness is the first step to ...
(Date:8/27/2014)... August 27, 2014 The Connecticut Community for ... on September 19, 2014, from 10:00 AM – 2:00 PM ... turn out from participants across the state to show their ... front of Connecticut’s state capitol. , Recovery Walks! is a ... addiction to alcohol and other drugs as well as their ...
(Date:8/26/2014)... Recently, BambooIndustry.com, the popular online supplier of bamboo ... floorings for the online market. Along with that, ... the new items are offered at greatly discounted prices, ... will end on September 10, 2014. , At ... with low shipping costs. The company wants to offer ...
(Date:8/26/2014)... In its latest blog post, Best ... that having family close by during a stay in ... not the process is successful, is looking at 6 ... people need medication to help them overcome addiction, particularly ... triggers like anxiety and depression, many others will be ...
Breaking Medicine News(10 mins):Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 3
(Date:8/26/2014)... SynCardia Systems, Inc., manufacturer of the SynCardia ... 5000 named by the business magazine Inc. ... Canada and CE approved Total Artificial Heart, which is ... transplant," says Michael P. Garippa , SynCardia,s CEO ... for patients dying from end-stage biventricular heart failure." ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
Breaking Medicine Technology:Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
Cached News: